[go: up one dir, main page]

MX2012000041A - Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta. - Google Patents

Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.

Info

Publication number
MX2012000041A
MX2012000041A MX2012000041A MX2012000041A MX2012000041A MX 2012000041 A MX2012000041 A MX 2012000041A MX 2012000041 A MX2012000041 A MX 2012000041A MX 2012000041 A MX2012000041 A MX 2012000041A MX 2012000041 A MX2012000041 A MX 2012000041A
Authority
MX
Mexico
Prior art keywords
metastatic cancer
predisposed
testing
subject
subject thought
Prior art date
Application number
MX2012000041A
Other languages
English (en)
Other versions
MX341181B (es
Inventor
Pierre Roux
Gilles Gadea
Stephanie Vinot
Christelle Anguille
Jean-Christophe Bourdon
Kenneth Fernandes
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of MX2012000041A publication Critical patent/MX2012000041A/es
Publication of MX341181B publication Critical patent/MX341181B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4748—Details p53
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se relaciona con un método para someter a prueba a un sujeto que se cree está predispuesto a tener un cáncer metastásico que comprende el paso de i) analizar una muestra biológica de dicho sujeto para detectar la presencia de una isoforma p53 seleccionada en el grupo que consta de 133p53, 133p53y y 133p533, la presencia de dicha isoforma p53 siendo indicativa de un cáncer metastásico.
MX2012000041A 2009-06-30 2010-06-30 Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta. MX341181B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22176909P 2009-06-30 2009-06-30
EP09305633A EP2272979A1 (en) 2009-06-30 2009-06-30 Method for testing a subject thought to be predisposed to having cancer
PCT/EP2010/059321 WO2011000891A1 (en) 2009-06-30 2010-06-30 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta

Publications (2)

Publication Number Publication Date
MX2012000041A true MX2012000041A (es) 2012-04-19
MX341181B MX341181B (es) 2016-08-09

Family

ID=41119348

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000041A MX341181B (es) 2009-06-30 2010-06-30 Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.

Country Status (9)

Country Link
US (1) US20120115151A1 (es)
EP (2) EP2272979A1 (es)
JP (1) JP2012531606A (es)
CN (1) CN102471801B (es)
BR (1) BRPI1011929A2 (es)
CA (1) CA2766317C (es)
ES (1) ES2601191T3 (es)
MX (1) MX341181B (es)
WO (1) WO2011000891A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014006227A1 (en) 2012-07-06 2014-01-09 Institut Gustave-Roussy Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
CN102924594B (zh) * 2012-08-03 2014-05-07 无锡傲锐东源生物科技有限公司 抗肿瘤蛋白p63单克隆抗体及其用途
CN102827278B (zh) * 2012-08-03 2014-04-23 无锡傲锐东源生物科技有限公司 抗肿瘤蛋白p53单克隆抗体及其用途
WO2016120493A1 (en) * 2015-01-30 2016-08-04 Centre National De La Recherche Scientifique (Cnrs) Reprogramming method for producing induced pluripotent stem cells (ipsc)
CN107208066B (zh) * 2015-01-30 2022-09-30 国家科学研究中心 Δ133P53β和Δ133P53γ同种型是癌症干细胞的生物标记物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
WO1987002671A1 (en) 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL91501A (en) 1988-09-02 1998-03-10 Dyax Corp Generation of a variegated library of mutant potential binding proteins and screening of said library for proteins with a desired binding activity
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ATE164395T1 (de) 1990-12-03 1998-04-15 Genentech Inc Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
ATE363532T1 (de) 1991-03-01 2007-06-15 Dyax Corp Verfahren zur herstellung bindender miniproteine
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE10234739A1 (de) * 2002-07-30 2004-02-12 Universitätsklinikum Hamburg-Eppendorf Splicing-Variante des humanen p53-Proteins und deren Verwendung zur Herstellung pharmazeutischer Präparate zur Behandlung von Tumorerkrankungen
CN1970763A (zh) * 2006-12-18 2007-05-30 北京市结核病胸部肿瘤研究所 一种截短的抑癌基因p53增加人肺癌细胞对抗肿瘤药物敏感性
WO2009029054A1 (en) * 2007-08-31 2009-03-05 Agency For Science, Technology And Research P53 isoform gene(s) and uses thereof
FR2957821B1 (fr) 2010-03-24 2014-08-29 Inst Francais Du Petrole Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives

Also Published As

Publication number Publication date
US20120115151A1 (en) 2012-05-10
WO2011000891A1 (en) 2011-01-06
MX341181B (es) 2016-08-09
EP2449133B1 (en) 2016-08-03
CN102471801A (zh) 2012-05-23
EP2272979A1 (en) 2011-01-12
CA2766317C (en) 2019-04-02
JP2012531606A (ja) 2012-12-10
BRPI1011929A2 (pt) 2016-04-19
CA2766317A1 (en) 2011-01-06
ES2601191T8 (es) 2017-06-09
ES2601191T3 (es) 2017-02-14
EP2449133A1 (en) 2012-05-09
CN102471801B (zh) 2016-05-11

Similar Documents

Publication Publication Date Title
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2419717A4 (en) FLUORESCENCE SENSOR, FLUORESCENCE SENSOR IN NEEDLE FORM AND ANALYTIC MEASUREMENT METHOD
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
EP2582847A4 (en) METHODS AND MATERIALS FOR EVALUATING LOSS OF HETEROZYGOTIA
MX2009013107A (es) Metodos y aparatos para analizar muestras y recoger fracciones de muestra.
IN2012DN03156A (es)
AP2011005691A0 (en) Modified apparatus and method for assessment, evaluation and grading of gemstones.
EP2383575A4 (en) SAMPLE PRETREATMENT METHOD AND BIOLOGICAL SUBSTANCE ANALYSIS METHOD
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
MX2010003424A (es) Medicion de propiedades mecanicas.
MX352971B (es) Compensacion para diafonia espectral en amplificacion de acido nucleico multiplexado.
GB2474146A (en) Methods of determining the health status of an individual
GB2511221A (en) Methods and compositions for classification of samples
SG194233A1 (en) Identification of polynucleotides associated with a sample
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
NZ602369A (en) Anti-cxcr1 compositions and methods
WO2012096545A3 (ko) 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도
EP2270421A4 (en) LIQUID SAMPLE ANALYSIS METHOD
WO2011116006A3 (en) A rapid method to measure cyanide in biological samples
WO2009105212A3 (en) Detection of polyomavirus
GB0805814D0 (en) Biosensor for analyte detection
WO2007114986A3 (en) Cooperative probes and methods of using them
GB0814035D0 (en) Apparatus and method for biological sample culture or testing
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis

Legal Events

Date Code Title Description
FG Grant or registration